Folk J C, Kumar V, Piper J G, Barcellos W A, Schoenwald R D, Chien D S
Arch Ophthalmol. 1986 Aug;104(8):1192-3. doi: 10.1001/archopht.1986.01050200098059.
We performed four studies to determine whether there is a difference in the mydriatic effect of 2.5% aqueous vs 2.5% viscous phenylephrine hydrochloride solutions. The first study was performed under "room light" conditions, and the mean (+/- SD) dilation at one hour was 0.87 +/- 1.18 mm for the aqueous and 0.86 +/- 1.14 mm for the viscous solutions. The second study was performed in a darkened room, and the mean dilation at one hour was slightly greater than in room light but was still minimal (aqueous, 1.14 +/- 1.00 mm; viscous, 1.07 +/- 1.11 mm). In the third study, patients were pretreated with a topical anesthetic (0.5% proparacaine hydrochloride), and the mean one-hour dilation was approximately twice (aqueous, 2.30 +/- 0.81 mm; viscous, 2.41 +/- 0.88 mm) that found in patients who were not pretreated with proparacaine. In the fourth study, the two phenylephrine solutions were used in combination with 1% tropicamide, and the mean one-hour dilation was 3.8 +/- 0.82 mm for the aqueous and 3.8 +/- 0.98 mm for the viscous solutions. Our studies show that there is no difference in the mydriatic effect of 2.5% aqueous vs 2.5% viscous phenylephrine solutions when used alone or in combination with 0.5% proparacaine or 1% tropicamide.
我们进行了四项研究,以确定2.5%水剂型与2.5%粘性盐酸去氧肾上腺素溶液的散瞳效果是否存在差异。第一项研究在“室内光线”条件下进行,水剂型溶液在一小时时的平均(±标准差)瞳孔散大值为0.87±1.18毫米,粘性溶液为0.86±1.14毫米。第二项研究在暗室中进行,一小时时的平均瞳孔散大值略大于室内光线条件下,但仍然很小(水剂型,1.14±1.00毫米;粘性,1.07±1.11毫米)。在第三项研究中,患者用一种局部麻醉剂(0.5%盐酸丙美卡因)预处理,一小时时的平均瞳孔散大值约为未用丙美卡因预处理患者的两倍(水剂型,2.30±0.81毫米;粘性,2.41±0.88毫米)。在第四项研究中,两种去氧肾上腺素溶液与1%托吡卡胺联合使用,水剂型溶液一小时时的平均瞳孔散大值为3.8±0.82毫米,粘性溶液为3.8±0.98毫米。我们的研究表明,单独使用或与0.5%丙美卡因或1%托吡卡胺联合使用时,2.5%水剂型与2.5%粘性去氧肾上腺素溶液的散瞳效果没有差异。